- Category
- Micro (2024-25)
- Udyam number
- UDYAM-TN-08-0021567

About Superb Formulations Private Limited
Data last updated:
Superb Formulations Private Limited is a private limited company based in Kanchipuram, Tamil Nadu, India. It operates in the flavouring and seasoning additives segment of the food and beverages sector. It was incorporated on 06 October 2015 and has been in existence for over 11 years.
The company is registered with the Registrar of Companies (ROC), Chennai, under CIN U15139TN2015PTC102475. Its GSTIN is 33AAWCS2781F1ZZ (Tamil Nadu). The company holds 11 GST registrations, of which 9 are active.
The company has an authorised share capital of ₹3 Cr and a paid-up capital of ₹1.93 Cr. It is led by directors Madanamuthu Parameswaran and Sulakshan Parameswaran.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Kanchipuram, Tamil Nadu.
As per the financials filed for FY 2025, the company reported a revenue of ₹5.52 Cr, a growth of 16% compared to the previous year. For the same year it recorded a net profit of ₹2.27 Lakh (net margin 0.4%) and EBITDA of ₹50.81 Lakh (EBITDA margin 9.2%). Revenue has grown at a compounded annual rate (CAGR) of 8% over three years and 13% over five years.
The company is associated with 2 brands: Ossoro and Superb Formulations. As per MCA filings, the company has open charges of ₹2.51 Cr on record.
Superb Formulations Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-TN-08-0021567). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website superbformulations.com.
Recognitions & Rankings of Superb Formulations
- EmailLocked
- TelephoneLocked
- Website
- Social Media
- Registered Address1/236 New No – 1/223 Kamaraj Street Vandaloor Road Pudupakk, Am Village, Kanchipuram, Tamil Nadu, India – 603103
- IndustryFood and Beverages, Flavouring & Seasoning Additives
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Associated Brands with Superb Formulations Private Limited
Superb Formulations operates two associated brands: Ossoro and Superb Formulations. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Flavor extracts, essences, and customization services in the food and beverage sector. | ossoro.com | |
| Flavor creation and development services for food products in Chennai. | superbformulations.com |
Business Activity of Superb Formulations Private Limited
The main business activity of Superb Formulations is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Superb Formulations Private Limited FY 2024 filings available
Superb Formulations Private Limited reported revenue of ₹5.52 Cr (up 16% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Superb Formulations Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 13% over five years, including 16% growth in the latest year. EBITDA rose 9% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Superb Formulations Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹50.81 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹2.27 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Superb Formulations Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 9.2% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 0.4% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Superb Formulations are in the company report.
Financial statements from FY 2016
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Superb Formulations Private Limited
Superb Formulations has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Madanamuthu Parameswaran | Director | 06 Oct 2015 | 11 Years 0 Months | Current |
| Sulakshan Parameswaran | Director | 06 Oct 2015 | 11 Years 0 Months | Current |
Peer Comparison of Superb Formulations Private Limited
Superb Formulations Private Limited is compared with the companies closest to it by revenue in the Food and Beverages industry (Flavouring and Seasoning Additives, Formulations). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Element Pharmaceuticals Private Limited | ₹5.58 Cr (FY 2025) | •••• | •••• | -4.0% | •••• | Pune, Maharashtra, India |
| Alzey Pharmaceuticals Private Limited | ₹5.56 Cr (FY 2025) | •••• | •••• | -21.0% | •••• | Barwala, Haryana, India |
| Rishab Healthcare Private Limited | ₹5.56 Cr (FY 2025) | •••• | •••• | -21.0% | •••• | Chandigarh, India |
| Hasita Aromatics Private Limited | ₹5.54 Cr (FY 2025) | •••• | •••• | -24.0% | •••• | Telangana, India |
| Salmed Laboratories Private Limited | ₹5.53 Cr (FY 2025) | •••• | •••• | 29.0% | •••• | Ahmedabad, Gujarat, India |
| Superb Formulations Private Limited this company | ₹5.52 Cr (FY 2025) | •••• | •••• | 16.0% | •••• | Kanchipuram, Tamil Nadu, India |
| Household Remedies Private Limited | ₹5.52 Cr (FY 2025) | •••• | •••• | -27.0% | •••• | Thane, Maharashtra, India |
| Research Medicine Private Limited | ₹5.52 Cr (FY 2025) | •••• | •••• | -2.0% | •••• | New Delhi, Delhi, India |
| Anabond Stedman Pharma Research Private Limited | ₹5.51 Cr (FY 2024) | •••• | •••• | 17.0% | •••• | Chennai, Tamil Nadu, India |
| Lifecare Formulation Private Limited | ₹5.51 Cr (FY 2025) | •••• | •••• | 16.0% | •••• | Ahmedabad, Gujarat, India |
| Medilief Biosciences Private Limited | ₹5.5 Cr (FY 2025) | •••• | •••• | -1.0% | •••• | New Delhi, Delhi, India |
Peers are the five companies nearest above and the five nearest below Superb Formulations by revenue in the Food and Beverages industry (Flavouring and Seasoning Additives, Formulations), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Superb Formulations Private Limited
Superb Formulations Private Limited is audited by Ramesh and Ramachandran for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| Ramesh and Ramachandran | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Superb Formulations Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Superb Formulations Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 31 May 2025 | Hdfc Bank Limited | ₹13.39 Lakh | Open |
| 12 Jun 2024 | Hdfc Bank Limited | ₹37.95 Lakh | Open |
| 27 Jun 2017 | City Union Bank Limited | ₹1.92 Cr | Open |
| 28 Jul 2016 | Others | ₹7.5 Lakh | Open |
Total charge records: 4 View all charges
Employees and EPFO Compliance at Superb Formulations Private Limited
Superb Formulations Private Limited has a workforce of 0 employees as of Dec 14, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Superb Formulations Private Limited
Superb Formulations Private Limited has 2 board changes on record since 2015: 2 appointments. The latest: Madanamuthu Parameswaran was appointed as Director on 06 Oct 2015.
Credit Ratings, Litigation & Regulatory Alerts for Superb Formulations Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Superb Formulations Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Superb Formulations Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Superb Formulations Private Limited
Superb Formulations has 11 GST registrations: 9 active and 2 cancelled or inactive. The first 4 active GSTINs are listed below.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 33AAWCS2781F1ZZ | Tamil Nadu | Active | 01 Jul 2017 |
| 07AAWCS2781F1ZU | Delhi | Active | 12 Nov 2020 |
| 29AAWCS2781F1ZO | Karnataka | Active | 13 Oct 2023 |
| 27AAWCS2781F2ZR | Maharashtra | Active | 27 Nov 2023 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Superb Formulations Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Superb Formulations Private Limited
Superb Formulations is an active private limited company based in Kanchipuram, Tamil Nadu, India. The company works in flavouring and seasoning additives, within the food and beverages industry. It was incorporated on 06 October 2015 (11+ years old) and is registered under CIN U15139TN2015PTC102475.
Superb Formulations reported revenue of ₹5.52 Cr for FY 2025 (up 16% YoY).
Superb Formulations has 2 current directors:
- Madanamuthu Parameswaran - Director
- Sulakshan Parameswaran - Director
Superb Formulations reported a net profit of ₹2.27 Lakh (net margin 0.4%) and EBITDA of ₹50.81 Lakh (EBITDA margin 9.2%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Superb Formulations is 8% over three years and 13% over five years. In the latest year (FY 2025) revenue rose 16%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Superb Formulations is 33AAWCS2781F1ZZ, registered in Tamil Nadu. The company has 11 GST registrations in all, of which 9 are active and 2 are cancelled or inactive. Other active GSTINs include 07AAWCS2781F1ZU (Delhi), 29AAWCS2781F1ZO (Karnataka), 27AAWCS2781F2ZR (Maharashtra).
The CIN (Corporate Identification Number) of Superb Formulations is U15139TN2015PTC102475. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Superb Formulations was incorporated on 06 October 2015, making it 11+ years old. It is registered with the Registrar of Companies, Chennai.
The peers of Superb Formulations by revenue are Element Pharmaceuticals Private Limited, Alzey Pharmaceuticals Private Limited, Rishab Healthcare Private Limited, Hasita Aromatics Private Limited, Salmed Laboratories Private Limited and 5 more, all in the Food and Beverages industry (Flavouring and Seasoning Additives, Formulations).
Madanamuthu Parameswaran was appointed as Director on 06 Oct 2015. Sulakshan Parameswaran was appointed as Director on 06 Oct 2015.
Yes, Superb Formulations is registered as a micro enterprise under Udyam registration (number: UDYAM-TN-08-0021567).